Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing
BioPharm
Sponsored by Cytiva
Biopharma Trends
Upstream
Downstream
Regulatory/QbD
Articles
Subscribe to Enews
Join LinkedIn Group
Share This Page
Email
Facebook
Twitter
March 24, 2022
mRNA vaccines: current trends and perspectives
Cytiva
The promise and challenges of mRNA vaccine development.
READ MORE >>
Related Content
Process Development challenges for mRNA vaccines and beyond
mRNA Therapeutics and Vaccines – Key Process Considerations
Cytiva to provide Arranta Bio 'idea to injection' solutions for integrated manufacturing of mRNA products
Increasing mRNA Capabilities and Capacity for Growing Market Needs
mRNA: the messenger
See All Articles…
